Diacylglycerol kinase (DGK) phosphorylates and converts diacylglycerol (DAG) to phosphatidic acid. DGK regulates cellular DAG levels and attenuates DAG signaling. The ten mammalian DGK isoforms have been identified to date. In cardiac myocytes, DGKα, ε, and ζ are expressed, and DGKζ is the predominant isoform. DGKζ inhibits protein kinase C activation and subsequent hypertrophic programs in response to endothelin-1 in neonatal rat cardiomyocytes. DGKζ blocks cardiac hypertrophy induced by G protein-coupled receptor agonists and pressure-overload in vivo. DGKζ attenuates ventricular remodeling and improves survival after myocardial infarction. These data provide a novel insight for subcellular mechanisms of cardiac hypertrophy and heart failure, and DGKζ may be a new therapeutic target to prevent cardiac hypertrophy and progression to heart failure.
Introduction
Phosphoinositide turnover is one of the key events to transducer signals of development, differentiation, and mitogenesis in response to a variety of extracellular stimuli (Cocco et al., 2004; Gonzales & Anderson, 2006) . Multiple lines of experimental and clinical evidence have suggested the importance of the Gαq-phosphoinositide signaling system in the development of pathologic cardiac hypertrophy and heart failure (D'Angelo et al, 1997; Mende et al., 1998; Hunter et al., 1999) . Gq protein-coupled receptor (GPCR) agonists such as angiotensin II (Sadoshima et al., 1993; Oro et al., 2007) , endothelin-1 (Shubeita et al., 1990) , and phenylephrine (Otani et al., 1988 ) activate phospholipase C-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate, which causes a transient increase in levels of cellular diacylglycerol (DAG) and inositol 1,4,5-trisphosphate ( Figure 1 ). DAG functions as a potent activator of protein kinase C (PKC). The binding of DAG to the C1 domain of PKC induces an active conformation, and activated PKC regulates a variety of cellular functions including cell growth and differentiation (Nishizuka 1988; Nishizuka 1992) .
It has been previously demonstrated that PKC plays an important role in the development of cardiac hypertrophy and progression to heart failure (Takeishi et al., 1998; Bowling et al., 1999; Takeishi et al., 1999; Takeishi et al. 2000) . One major route for terminating DAG signaling is thought to be its phosphorylation and inactivation by DAG kinase (DGK) 6 producing phosphatidic acid (Goto & Kondo, 2004; Luo et al., 2004; Goto et al., 2006) . One of the best known functional roles of DGK is to regulate PKC activity through DAG metabolism (Topham et al., 1998; Topham & Prescott, 1999) . However, recent reports have suggested that the functional significance of DAG is not restricted to PKC pathway, and DAG also activates several proteins including Ras GRP (Ebinu et al., 1998) , protein kinase D (Baron & Malhotra, 2002) , and transient receptor potential proteins (Hofmann et al., 1999) .
These data suggest that DAG is more widely implicated in cellular events and cellular DAG level is strictly controlled to maintain normal physiological conditions (Figure 1 ). In addition, phosphatidic acid produced by DGK has signaling functions and serves as a lipid second messenger to regulate a variety of signaling proteins including PKCζ (Limatola et al., 1994 ) and phospholipase C γ1 (Jones & Carpenter, 1993) . Therefore, DGK is one of the key enzymes closely involved in lipid-mediated cellular signaling events by attenuation of DAG and production of phosphatidic acid (Topham, 2006; Wattenberg et al., 2006) .
Expressions of DGK isoforms in the heart

The mammalian DGK family
DGKα was firstly cloned from porcine thymus cDNA library (Sakane et al., 1990 ).
This contains two EF bands and two cysteine-rich zinc finger motifs in addition to the 7 catalytic domain in the primary structure. To date, ten DGK isoforms have been identified in mammals such as DGKα, β, γ, δ, ε, ζ, η, θ, ι, and κ (Goto & Kondo, 2004; Luo et al., 2004; Imai et al., 2005; Goto et al., 2006) . All of the mammalian DGK isoforms contain a conserved catalytic domain and zinc finger motifs rich in cysteine residues. The zinc finger motifs in DGK resemble C1 domains found in PKC. In the presence of zinc ions, C1 domains of PKC bind DAG and its analogues, phorbol esters, which activate PKC. DGKα, β, and γ belong to the class I family characterized by the presence of a Ca -dependent conformational changes (Yamada et al., 1997) . DGKδ and η belong to the class II that contains pleckstrin homology domains. The pleckstrin homology domain interacts with phosphatidylinositol 4,5-bisphosphate, inositol phosphate, PKC, and βγ-subunit of heterotrimeric G proteins . DGKε belongs to the class III, and is highly selective for DAG containing arachidonate as the sn-2 fatty acyl moiety (Walsh et al., 1994) . Class IV includes DGKζ and ι, characterized by a nuclear localization signal and ankyrin repeats. The nuclear localization signal sequence overlaps with a motif similar to the phosphorylation site domain of the myristoylated alanine-rich C-kinase substrate proteins (Bunting et al., 1996) . The ankyrin repeat motif is involved in protein-protein interactions (Blank et al., 1992) . Class V includes DGKθ characterized by the presence of zinc finger 8 motifs, a protein-rich region at the N-terminus, and a pleckstrin homology domain in the middle of the structure that partially overlaps with a putative Ras-associated domain (Houssa et al., 1997) . In mammals, DGK isoforms are detected in various tissues and cell types, suggesting the importance of this kinase in basic cellular functions.
DGK isoform expression in the heart after myocardial infarction
Although DGK isoforms are abundantly expressed in the brain, Takeda et al. firstly investigated expression of DGK isoforms in rat hearts under a normal condition and after myocardial infarction by in situ hybridization histochemistry and immunohistochemistry (Takeda et al., 2001) . In normal left ventricular myocardium, DGKα, DGKε, and DGKζ mRNAs are expressed, and DGKζ is the predominant isoform. In infarcted hearts, the expression of DGKζ is enhanced in the peripheral zone of the necrotic area and at the border zone at 3 and 7 days after myocardial infarction. However, they mentioned the possibility that the enhanced DGKζ expression in the infarcted and border areas could be attributed to granulocytes and macrophages infiltrated in the myocardium (Takeda et al., 2001) . In contrast, the DGKε expression is decreased in the left ventricle after myocardial infarction.
These results suggest that each DGK isoform might have different functional characteristics in the healing and left ventricular remodeling after myocardial infarction. 
DGKζ mRNA expression after ET-1 stimulation
DGKζ is the first nuclear isoform identified and this was confirmed by cDNA transfection into cultured COS cells (Goto and Kondo, 1996) . DGKζ associates with a variety of molecules via the C-terminal ankyrin repeats and PDZ-binding motif. DGKζ is widely and abundantly expressed throughout the body including the heart, and Takahashi et el.
examined changes in DGKζ mRNA expression after endothelin-1 (ET-1) stimulation in 
Regulatory role of DGKζ in cultured neonatal rat cardiomyocytes
DGKζ blocks ET-1-induced PKCε translocation and ERK activation
Although the functional role of DGK has been well characterized in the central nervous system, the functional significance of the DGK family has not been rigorously examined in the cardiovascular system. To examine the effect of DGKζ on subcelluler signaling in the cardiomyocyte, a recombinant adenovirus encoding for rat DGKζ was used (Takahashi et al., 2005) . It has been reported that ET-1, a potent hypertrophic agonist, causes the translocation of PKCε to the membrane fraction in rat neonatal cardiomyocytes (Clerk et al., 1994) . Therefore, Takahashi 
Inhibition of ET-1-induced AP1 DNA-binding activity by DGKζ
ET-1-induced activation of the PKCε-ERK pathway leads to activation of the activator protein-1 transcription factor thereby promoting the transcription of immediate-early genes such as c-fos and c-jun (Takahashi et al., 2004 
. DGKζ blocks GPCR agonist-induced activation of the DAG-PKC signaling
To examine the functional role of DGKζ in in vivo hearts, Arimoto et al. generated a transgenic mouse with cardiac specific overexpression of DGKζ (DGKζ-TG) using an α-myosin heavy chain (MHC) promoter (Arimoto et al., 2006) . DGKζ-TG and wild type littermate (WT) mice were assessed with respect to their susceptibility to hypertrophic response to subpressor doses of subcutaneous angiotensin II (Harada et al., 1998) Then, lipid extracts were prepared from the left ventricular myocardium, and
Arimoto et al. quantified myocardial DAG levels in WT and DGKζ-TG mouse hearts (Arimoto et al., 2006) . At basal condition, DAG levels were similar between WT and DGKζ-TG mice. In WT mouse hearts, myocardial DAG level increased significantly after continuous administration of phenylephrine for 3 days. On the other hand, this effect of phenylephrine on myocardial DAG levels was completely suppressed in DGKζ-TG mouse hearts. These data support the notion that DGKζ regulates PKC activity by controlling cellular DAG levels. 
Effects of DGKζ on hypertrophic programs in response to GPCR agonists
Ventricular hypertrophy induced by continuous infusion of angiotensin II or phenylephrine is accompanied by the induction of several specific genes such as ANF (Harada et al., 1998; Takahashi et al., 2005) . The mRNA expression of ANF was increased in WT mice given angiotensin II and phenylephrine compared to saline-infused WT mice (Arimoto et al., 2006) . However in DGKζ-TG mice, angiotensin II failed to cause gene induction of ANF. Phenylephrine-induced ANF gene induction was also blocked in DGKζ-TG mice. These data suggest that DGKζ blocks hypertrophic gene induction by angiotensin II and phenylephrine in in vivo mouse hearts.
Heart weight and left ventricular weight corrected for body weight were not significantly different between saline-infused WT and saline-infused DGKζ-TG mice.
Subcutaneous infusion of angiotensin II and phenylephrine caused significant increases in ratios of: a) heart to body weight; and b) left ventricle to body weight in WT mice. However in DGKζ-TG mice, neither angiotensin II nor phenylephrine produced increases in ratios of the heart to body weight and ratios of the left ventricle to body weight.
Microscopic observations revealed that no significant difference in cardiomyocyte cross sectional area was seen between saline-infused WT and saline-infused DGKζ-TG mice.
In WT mice, cardiomyocyte cross sectional area was significantly increased by angiotensin II and phenylephrine infusion. However in DGKζ-TG mice, neither angiotensin II nor phenylephrine caused increases in cardiomyocyte cross sectional area. Taken together, these data clearly demonstrate that DGKζ might interfere with GPCR agonist-induced cardiac hypertrophy.
Pressure overload-induced cardiac hypertrophy
Cardiac hypertrophy after tranverse aortic constriction in DGKζ-TG mice
In the clinical setting, mechanical stress is more relevant and important as a cause of cardiac hypertrophy. Therefore, to examine the effects of DGKζ on mechanical stress-induced cardiac hypertrophy, Harada et al. performed transverse aortic constriction (TAC) in DGKζ-TG and WT mice (Harada et al., 2007) . Extensive cardiac hypertrophy due to pressure-overload was observed at 4 weeks after TAC in WT mice. However in DGKζ-TG mice, cardiac hypertrophy after TAC was significantly attenuated. At 4 weeks after TAC surgery, the ratio of heart weight to body weight was significantly lower in DGKζ-TG mice than in WT mice.
Microscopic observations revealed that no significant difference in cardiomyocyte cross sectional area was seen between sham-operated WT mice and sham-operated DGKζ-TG mice. Cardiomyocyte cross sectional area was increased in WT mice at 4 weeks after TAC.
However, increases in cardiomyocyte cross sectional area after TAC were significantly attenuated in DGKζ-TG mice compared to WT mice.
Echocardiography was performed at baseline and 4 weeks after TAC or sham surgery in WT and DGKζ-TG mice. Interventricular septal wall thickness and left ventricular end-diastolic dimension were significantly increased in WT mice after TAC. However in DGKζ-TG mice, the increase in interventricular wall thickness after TAC was attenuated compared to WT mice. Moreover, the reduction of left ventricular fractional shortening at 4 weeks after TAC was attenuated in DGKζ-TG mice compared to WT mice.
Expressions of fetal genes in hypertrophied hearts
Harada and colleagues (Harada et al, 2007) next examined mRNA expression of fetal type genes such as ANF and β-MHC at 4 weeks after TAC in WT and DGKζ-TG mice by real-time RT-PCR. Expression of ANF was markedly up-regulated in WT mice after TAC.
Conversely in DGKζ-TG mice, gene induction of ANF in responses to TAC was significantly attenuated compared to WT mice. The β-MHC/α-MHC ratio was also markedly increased in WT mice after TAC, but this response was blunted in DGKζ-TG mice.
Myocardial fibrosis and expressions of profibrotic genes
Since reactive interstitial and perivascular fibrosis adversely alters myocardial stiffness and ultimately leads to left ventricular dysfunction (Kuwahara et al., 2004) , Harada et al. examined myocardial fibrosis at 4 weeks after TAC in WT and DGKζ-TG mice using sections stained with Masson trichrome (Harada et al, 2007) . Prominent fibrosis was observed in WT mice at 4 weeks after TAC as reported previously (Takimoto et al., 2005) .
However, the degree of myocardial fibrosis was much less in DGKζ-TG mice than in WT mice at 4 weeks after TAC. These results indicated that, although pressure-overload caused fibrous formation in the left ventricular myocardium, reactive fibrosis was significantly attenuated by DGKζ.
Harada et al. next examined expression of profibrotic genes such as transforming growth factor (TGF)-β1, collagen type I, and collagen type III to investigate whether these morphological observations were accompanied by alterations in gene expression relevant to fibrotic changes (Lijnen et al, 2000; Manabe et al., 2002) . Real-time RT-PCR revealed that TGF-β1, collagen type I, and collagen type III mRNA at 4 weeks after TAC were up-regulated in WT mice. However, these increases in collagen type I and type III mRNA, but not TGF-β1, were significantly attenuated in DGKζ-TG mice compared to WT mice. 
Ventricular remodeling after myocardial infarction
Effects of DGKζ on left ventricular remodeling after myocardial infarction
Niizeki et al. examined effects of DGKζ on left ventricular remodeling after myocardial infarction in DGKζ-TG mice . Left anterior descending coronary artery was ligated, and mice were sacrificed 4 weeks later. At 4 weeks after myocardial infarction, the ratio of heart weight to body weight and the ratio of left ventricular weight to body weight were significantly lower in DGKζ-TG mice than in WT mice. Lung weight and right ventricular weight at 4 weeks after myocardial infarction were also significantly lower in DGKζ-TG mice than in WT mice, although infarct size at 4 weeks after coronary ligation was similar between WT and DGKζ-TG mice.
Echocardiography was performed at baseline, 1 week, and 4 weeks after surgery in WT and DGKζ-TG mice. Left ventricular end-diastolic dimension was significantly larger in WT mice at 1 week after myocardial infarction compared to sham-operated WT mice, and left ventricular end-diastolic dimension was further dilated at 4 weeks after myocardial infarction. However, ventricular dilatation after myocardial infarction was prevented in DGKζ-TG mice compared to WT mice. Moreover, the reduction of left ventricular fractional shortening after myocardial infarction was attenuated in DGKζ-TG mice compared to WT mice at 4 weeks after coronary artery ligation. 
Translocation of PKC isoforms, expression of fetal genes and cardiomyocyte hypertrophy
Niizeki and colleagues examined translocation of PKC isoforms in the non-infarct area of DGKζ-TG and WT mice . They detected translocation of PKCα, β, δ, and ε isoforms at 4 weeks after myocardial infarction in the non-infarct area of WT mouse hearts. However in DGKζ-TG mice, translocation of PKCα and PKCε, but not β and δ, were significantly attenuated. Microscopic observations revealed that no significant difference in cardiomyocyte cross sectional area was seen between sham-operated WT and DGKζ-TG mice.
Cardiomyocyte cross sectional area in the non-infarct area was profoundly increased in WT mice at 4 weeks after myocardial infarction. However, increases in cardiomyocyte cross 21 sectional area after myocardial infarction was significantly attenuated in DGKζ-TG mice compared to WT mice.
DGKζ inhibits myocardial fibrosis in the non-infarct area
Since reactive interstitial and perivascular fibrosis in the non-infarcted area adversely alters myocardial stiffness and ultimately leads to left ventricular dysfunction (Lijinen et al., 2000; Shishido et al., 2003) , Niizeki et al. examined myocardial fibrosis in the non-infarct area at 4 weeks after myocardial infarction in WT and DGKζ-TG mice using sections stained with van Gieson stain . In the non-infarct area, prominent perivascular and interstitial fibrosis was observed in WT mice at 4 weeks after myocardial infarction as reported in previous studies (Shishido et al., 2003) . However, the degree of myocardial fibrosis at the non-infarct area was much less in DGKζ-TG mice than in WT mice at 4 weeks after myocardial infarction. These results indicated that, although coronary ligation caused fibrous formation in the infarct area and the size of myocardial infarction was similar between WT and DGKζ-TG mouse hearts, reactive fibrosis in the non-infarct area was significantly attenuated by DGKζ. 
Survival rates after myocardial infarction in DGKζ-TG mice
Myocardial infarction was created by coronary artery ligation in 93 WT mice and 82
DGKζ-TG mice . The rate of acute surgical death was not different between WT mice and DGKζ-TG mice. The survival rate until 4 weeks after myocardial infarction was significantly higher in DGKζ-TG mice (66%) than in WT mice (45%). The major cause of death in the first 10 days after myocardial infarction was cardiac rupture, and the incidence of cardiac rupture was not different between WT and DGKζ-TG mice. Thus, these differences in survival were due to less lethal congestive heart failure in DGKζ-TG mice than in WT mice.
Regulation of T cell activity by DGKζ
It has been widely recognized that T cell receptor engagement leads to T cell 23 activation (Kisielow et al. 1995; Kane et al, 2000) . 
Conclusion
Three DGK isoforms, α, ε, and ζ are expressed in cardiac myocytes, and DGKζ is the predominant isoform. DGKζ acts as a regulator of GPCR signaling by controlling cellular DAG levels and PKC activity. DGKζ blocks cardiac hypertrophy by GPCR agonists and pressure-overload, attenuates ventricular remodeling and improves survival after 24 myocardial infarction in vivo. These data provide a novel insight for subcellular mechanisms of heart failure, and DGKζ may be a new therapeutic target to prevent cardiac hypertrophy and progression to heart failure. The functional roles of two other isoforms, α and ε, in the heart remain to be elucidated.
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